Pan-cancer differentially methylated regions are promising biomarkers for non-invasive diagnosis in multiple cancers.

Moreover, as the number of cancer types increased, the differential methylation levels of pan-cancer DMRs also showed an increasing trend ( Figure S6 ).

also in 63,971 other papers